HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Surgical management of pheochromocytoma with the use of metyrosine.

Abstract
Despite recommended preoperative preparation with alpha-adrenergic blockers, severe hemodynamic instability may occur during operations to resect pheochromocytoma. We combined the alpha-blocker phenoxybenzamine with the tyrosine hydroxylase inhibitor metyrosine in an attempt to better manage the hypertension of patients with pheochromocytoma undergoing surgical resection. This report reviews the cases of 25 consecutive patients undergoing surgery for known intra-abdominal pheochromocytoma. Each patient had elevated serum or urine levels of catecholamines or their metabolites. Nineteen patients were prepared before operation with phenoxybenzamine and metyrosine and six patients were given phenoxybenzamine alone. There were no significant differences in maximum, minimum, or mean blood pressure before or after tumor resection between patients who received metyrosine and those who did not. However careful review suggested that those who received metyrosine had more severe disease as judged by biochemical criteria. Study of selected patients matched for age and severity of disease suggested that the intraoperative blood pressure management of patients prepared with phenoxybenzamine and metyrosine was facilitated. In addition metyrosine-prepared patients lost less blood and required less volume replacement during surgery than did non-metyrosine-prepared patients. There were no apparent differences in postoperative fluid requirements. Although the study is not a prospective randomized trial, a retrospective review of patients managed with the combination of phenoxybenzamine and metyrosine suggests that surgery to resect pheochromocytoma can be better performed with both drugs than with phenoxybenzamine alone. The combination regimen appears to result in better blood pressure control, less blood loss, and the need for less intraoperative fluid replacement than does the traditional method of single-agent alpha-adrenergic blockade.
AuthorsR R Perry, H R Keiser, J A Norton, R T Wall, C N Robertson, W Travis, H I Pass, M M Walther, W M Linehan
JournalAnnals of surgery (Ann Surg) Vol. 212 Issue 5 Pg. 621-8 (Nov 1990) ISSN: 0003-4932 [Print] UNITED STATES
PMID1978640 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Methyltyrosines
  • Phenoxybenzamine
  • alpha-Methyltyrosine
  • Tyrosine 3-Monooxygenase
Topics
  • Adrenal Gland Neoplasms (drug therapy, surgery)
  • Adult
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension (drug therapy)
  • Male
  • Methyltyrosines (therapeutic use)
  • Phenoxybenzamine (therapeutic use)
  • Pheochromocytoma (drug therapy, surgery)
  • Preoperative Care
  • Tyrosine 3-Monooxygenase (antagonists & inhibitors)
  • alpha-Methyltyrosine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: